Michael Mohler has a diverse work experience in intellectual property management and patent operations. Michael has served as an Executive Director - Patent Operations at Veru Inc., where they acted as a patent liaison and managed the company's patent portfolio. Michael also worked as a Consultant for Veru Inc., assisting with cost-benefit analysis and patent prosecution. Additionally, Michael has experience as a Consultant at Oncternal Therapeutics, supporting patent portfolios related to selective androgen receptor modulators (SARM) and selective androgen receptor degraders (SARD). Michael has also worked at GTx, Inc. as a Senior Research Scientist and Legal Liaison, where they supported the management of a large patent portfolio. Michael's work experience also includes serving as a Patent Liaison/Consultant for ChemBridge Corporation and as a Chair for the American Chemical Society.
Michael Mohler has a Bachelor of Science (B.S.) degree in Chemistry and Biology from the University of Tennessee at Martin. Michael also holds a Master of Science (M.S.) degree in Biochemistry and Molecular Biology from the University of Tennessee, Knoxville. Additionally, Mohler has a Doctor of Pharmacy (Pharm.D.) degree from the University of Tennessee Health Science Center and a Doctor of Philosophy (Ph.D.) degree in Pharmaceutical Sciences with a focus on Medicinal Chemistry Division from the same institution. Michael is also registered to practice before the USPTO as a Patent Agent with a Registration Number of 71,313.
November, 2020 - present
April, 2020